Hey {{first_name|there}} 👋 — here's your high-conviction breakdown for October 27.

TL;DR — Texas Instruments (NASDAQ: TXN)

  • The bull case: The backbone of physical electronics just posted a blowout quarter — Q3 revenue +28% to $6.06B, net income +78%, operating margin 47.5%, gross margin 64.2%, and free cash flow +249% as the heavy fab-building capex cycle finally crests. A world-class compounder firing on all cylinders, with a new data-center demand leg on top of autos and industrials.

  • The catch: The market already knows. The stock has nearly doubled off its 52-week low ($152.73) to $298, trading at ~39x trailing / 26x forward earnings, with only ~13% upside to the average target — and the low target ($250) sits 16% below today’s price.

  • Watch: Q3 just reported (Oct 21); next print is ~late January. The big cyclical surprise has already landed — and the stock already moved. No imminent catalyst from here.

The 10 Best Stocks for Fall 2026

MarketBeat analysts just updated their 10 Best Stocks to Own for Fall 2026 report. The list includes AI growth names, a high-yield dividend payer, a steady portfolio diversifier and companies positioned for continued growth into year-end. Get all 10 stocks and the research behind them for free now.

📊 Analyst Ratings

Metric

Figure

Read

Consensus rating

Buy

35 analysts

Avg price target

$336.86

~13% upside vs. $298

Median target

$340

~14% upside

Target range

$250 – $400

Low target ~16% below price

Recent price (Oct 26)

$298.12

+4.7% on the day

52-week range

$152.73 – $334.03

~11% below the high

Valuation

~39x / 26x

Trailing / forward P/E

Consensus in one line: a Buy, but the easy money looks made. Across 35 analysts the average target is ~$337 (median $340) against $298 today — only ~13% upside — while the low target ($250) sits ~16% below the current price. The quality is fully recognized; this is no longer a bottom-of-cycle bargain.

🏢 Company Overview

Texas Instruments designs the analog and embedded chips that turn real-world signals — heat, sound, pressure, voltage — into usable digital data. Rather than chasing bleeding-edge nanometer nodes, TI makes long-lived catalog chips that cost pennies, sell by the billions, and stay designed into cars and factories for decades. That’s what drives its structurally high margins (operating margin 47.5% in Q3). It’s a ~$272B-cap titan, now trading at $298 after nearly doubling off its 52-week low.

Q3 2026 revenue mix: Analog $4.91B (~81%), Embedded Processing $858M (~14%), Other $286M (~5%) — 80,000+ products sold to 100,000+ customers, mostly long-cycle industrial and automotive clients.

The 300mm moat: TI’s migration to internal 300mm wafer fabrication (mega-fabs in Sherman, TX and Lehi, UT) yields roughly a 40% chip-level cost advantage over legacy 200mm production — a widening structural edge as capacity ramps and peak construction spend normalizes.

From Our Partners

One idea. Backed by the analysts.

Join 130,000+ self-directed investors who get one trade idea a day, sourced from top Wall Street analysts and explained in plain English. Free, and a five-minute read.

Subscribe today for free

🌍 Macro & Industry Backdrop

TI sits at the crossroads of global factory output, corporate capex, and cross-border trade tension. Because its chips are embedded in nearly every electrical product, broad industrial activity — not consumer-tech fads — drives its top line.

  • Main risk: subsidized mature-node analog competition from domestic Chinese manufacturers, uneven European factory-automation demand, and — newly relevant — valuation risk: a cyclical name at ~39x earnings has little margin for a growth stumble.

  • Secular tailwinds: rising silicon content per vehicle (electrification, ADAS) and per factory (robotics), plus a genuine new data-center demand leg that showed up strongly in Q3.

📰 Recent Results & What’s Next

Q3 2026 (quarter ended Sept 30; reported Oct 21) was a blowout — and a clear signal the cyclical recovery is well past its bottom:

  • Revenue: $6.06B, +28% YoY.

  • Margins: gross 64.2%, operating 47.5% (+73% operating profit).

  • Net income: $2.43B, +78%; diluted EPS $2.62, +77%.

  • Free cash flow: $2.96B in Q3; $8.4B trailing twelve months (+249%) as peak fab-build capex crests.

  • Capital return: 23 consecutive years of dividend increases (recent ~7% hike); ~2.0% yield.

Q4 2026 guidance: revenue $5.80B–$6.30B (midpoint ~$6.05B — essentially flat sequentially, strong vs. the normal seasonal decline), EPS $2.45–$2.79.

⏰ Timing note: Q3 just reported Oct 21, so the next print (Q4 2026) is ~late January 2027. The big cyclical surprise has already landed — and the stock already moved. No imminent catalyst from here.

💼 Insider & Institutional Activity

Institutions own the story. Roughly 84–85% of shares are institutionally held, anchored by Vanguard, BlackRock, and State Street — a deep, stable base, now rewarded as free cash flow inflects hard out of the capex-heavy years.

Insiders: executive selling is disciplined and programmatic (Rule 10b5-1 option-exercise sales), not panic unloading; insider ownership is small relative to the float.

From Our Partners

A Little-Known Copper Miner is Positioned to Do Big Things

Electrification and data center demand are pushing copper into the spotlight, and its value climbing in response. Not many mining companies are able to provide the quality of copper to meet these demands, but one company with a district-scale property in the Yukon can. It's going to have a big year and so will anyone who invests in it.

Learn More Here

🏛️ Congressional Trades

Only sporadic, small-tier personal-portfolio trades — routine rebalancing, no policy-driven conviction. TXN isn’t a political-trade magnet.

📊 The Charts: Key Levels

TXN closed at $298.12, roughly 11% below its 52-week high of $334.03 and well into the upper third of its range after nearly doubling off the $152.73 low. This is a stock near its highs, not a base breakout.

  • Immediate resistance: $305–$312 (recent swing highs after the move)

  • Major resistance: $334 (52-week high / all-time-high zone)

  • First support: $280–$285 (pre-breakout shelf / recent consolidation)

  • Structural support: $250–$258 (prior base / low-end analyst target zone)

With RSI pushing into the upper range after a sharp move, momentum traders chasing here want a clean close above ~$312 before expecting a run at $334 — with a tight stop, since a cyclical name at 39x can reverse fast. Patient accumulators get far better risk-reward waiting for a pullback into the $280s (or lower) rather than buying the post-earnings spike.

📌 Key Takeaways

  • Blowout quarter, world-class business: +28% revenue, +78% net income, 47.5% operating margin, FCF +249%, 23 straight years of dividend growth, and a widening 300mm cost moat.

  • But the recovery is priced in: at $298 (~39x trailing / 26x forward), the stock has nearly doubled off its low and sits ~11% below its high, with only ~13% upside to the average target and ~16% downside to the low target.

  • New data-center leg is real: a genuine demand addition beyond the old industrial/auto story — a legitimate reason the Street raised targets.

  • No near-term catalyst: Q3 just reported; next print ~late January. The cyclical surprise has already happened.

🎯 The Bottom Line

Texas Instruments is a world-class industrial-grade compounder — but the setup today is “great business, mostly priced in,” not “quiet bargain at the bottom.” This is a $272B cash machine at $298 that has already staged a powerful recovery: Q3 revenue up 28%, profit up 78%, and free cash flow inflecting hard as the capex peak passes. The business quality is unquestionable, the 300mm moat is real, and the new data-center demand is a genuine bonus. The honest caveat is price: at ~39x trailing earnings, near its all-time high, with ~13% upside to consensus and a low target 16% below today’s price, most of the easy money has already been made. A wonderful business to own for the long compounding — just not an “asymmetric bottom-of-cycle” trade anymore. Be patient on entry, respect the valuation, and treat pullbacks, not breakouts, as your friend.

Disclaimer: Alpha Stocks Daily is for educational and informational purposes only and is not financial, investment, or trading advice. We are not registered investment advisors, and nothing here is a recommendation to buy or sell any security. Always do your own research and consult a licensed professional before investing. Past performance is not indicative of future results.